Craniometrix

Craniometrix is dedicated to improving the lives of dementia patients and their families, having secured over $21 million in funding to achieve this mission. Recognizing the significant challenges posed by dementia, Craniometrix focuses on providing comprehensive support to enable patients to age comfortably at home. Research indicates that targeted non-clinical coaching and support for families can prevent up to 30% of hospitalizations for dementia patients, a service now reimbursable by Medicare.

Launched in July 2025, Craniometrix's care navigation service has achieved $4 million in Annual Recurring Revenue (ARR) and recently completed a $15 million Series A funding round. By leveraging artificial intelligence, Craniometrix delivers exceptional care while reducing the workload on healthcare providers. Join the team and contribute to building a better future for dementia care.